263
Views
28
CrossRef citations to date
0
Altmetric
Miscellaneous

Novel biomaterials for drug delivery

&
Pages 1395-1410 | Published online: 25 Feb 2005

Bibliography

  • LANGER R: Biomaterials and biomedical engineering. Chem. Eng. Sci. (1995) 50(24):4109–4121.
  • LANGER R Biomaterials: new polymers and novel applications. MRS Bull. (1995) 20(8):18–22.
  • LANGER R: Drug delivery and targeting. Nature (1998) 392 (Suppl.):5S–10S.
  • ••Polymeric materials in drug deliverysystems.
  • LANGER R Biomaterial in drug delivery and tissue engineering: one laboratory's experience. Acc. Chem. Res. (2000) 33:94–101.
  • FEIJEN J: The impact of biomaterials on pharmaceutical sciences. Euro. J. Pharm. (1994) 2:7–9.
  • LEMONS JE: Ceramics: past, present, and future. Bone (1996) 19(1 Suppl.):121S–128S.
  • •Recent paper describing the development of ceramics as implants and its application in drug delivery.
  • KIMAKHE S, BOHIC S, LARROSE C et al.: Biological activities of sustained Polymyxin B release from calcium phosphate biomaterial prepared by dynamic compaction: an in vitro study. J. Biomed. Mater. Res. (1999) 47(1):18–27.
  • GAUTIER H, CAILLON J, LE RAY AM, DACULSI G, MERLE C: Influence of isostatic compression on the stability of vancomycin loaded with a calcium phosphate-implantable drug delivery device. J. Biomed. Mater. Res. (2000) 52(2):308–314.
  • GUICHEUX J, GAUTHIER O, AGUADO E et al.: Human growth hormone locally released in bone sites by calcium-phosphate biomaterial stimulates ceramic bone substitution without systemic effects: a rabbit study. J. Bone Miner. Res. (1998) 13(4):739–748.
  • GUICHEUX J, KIMAKHE S, HEYMANN D, DACULSI G: Growth hormone stimulates the degradation of calcium phosphate biomaterial by human monocytes/ macrophages in vitro. J. Biomed. Mater. Res. (1998) 40(1):79–85.
  • GAUTIER H, GUICHEUX J, GRIMANDI G, FAIVRE-CHAUVET A, DACULSI G, MERLE C: In vitro influence of apatite-granule-specific area on human growth hormone loading and release. J. Biomed. Mater. Res. (1998) 40(4):606–613.
  • LAMBOTTE JC, THOMAZEAU H, CATHELINEAU G, LANCIEN G, MINET J, LANGLAIS F: Tricalcium phosphate, an antibiotic carrier: a study focused on experimental osteomyelitis in rabbits. Chirurgie (1998) 123(6):572–9.
  • TAGAI T, HOSHI T, YAMADA T: Development of the porous apatitic materials. Kobutsugaku Zasshi (1997) 26(2):59–62.
  • RODRIGUEZ-LORENZO LM, SALINAS AJ, VALLET-REGI M, SAN ROMAN J: Composite biomaterials based on ceramic polymers. I. Reinforced systems based on A1203/PMMA/PLLA. J. Biomed. Mater. Res. (1996) 30(4):515–522.
  • HOFFMAN AS: Synthetic polymeric biomaterials. In: Polymeric materials and artificial organs. Gebelein Cg (Ed.). American Chemical Society, Washington DC, USA (1984):13–19.
  • HANES J, CHIBA M, LANGER R Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery. Biomaterials (1998) 19 (1-3) :163–172.
  • KIM D-D, TAKENO MM, RATNER, HORBETT TA: Glow discharge plasma deposition (GDPD) technique for the local controlled delivery of hirudin from biomaterials. Pharm. Res. (1998) 15(5):783–786.
  • SERIZAWA T, UCHIDA T, AKASHI M: Synthesis of polystyrene nanospheres having lactose-conjugated hydrophilic polymers on their surfaces and carbohydrate recognition by proteins. J. Biomater. Sci., Polym. Ed (1999) 10(3):391–401.
  • ••Site-specific drug carrier of lactoseconjugated polystyrene nanosphere.
  • BRUINING MJ, EDELBROEK-HOOGENDOORN PS, BLAAUWGEERS HGT, MOOY CM, HENDRIKSE FH, KOOLE LH: New biodegradable networks of poly(N-vinylpyrrolidinone) designed for controlled nonburst degradation in the vitreous body. J. Biomed. Mater. Res. (1999) 47(2):189–197.
  • SCHWARTE LM, PODUAL K, PEPPAS NA: Cationic hydrogels for controlled release of proteins and other macromolecules. ACS Symp. Ser. (1998) 709:56–66.
  • •Tailored polymeric materials for controlled delivery systems.
  • PEPPAS NA, KEYS KB, TORRES LM, LOWMAN AM: Poly (ethylene glycol)-containing hydrogels in drug delivery. J. Controlled Release (1999) 62(1-2):81–87.
  • •Mucoadhesive PEG star polymer hydrogels for protein delivery
  • BELL CL, PEPPAS NA: Swelling/syneresis phenomena in gel-forming interpolymer complexes. J. Biomater. Sci. Polym. Ed. (1996) 7(8):671–683.
  • JO S, PARK K: Novel poly(ethylene glycol) hydrogels from silylated PEGs. J. Bioact. Compat. Polym. (1999) 14(6):457–473.
  • HASSAN CM, STEWART JE, PEPPAS NA: Diffusional characteristics of freeze/thawed poly(vinyl alcohol) hydrogels: Application to protein controlled release from multilaminate devices. Euro. J. Pharm. Biopharm. (2000) 49(2):161–165.
  • NUTTELMAN CR, ANSETH KS: Attachment of proteins to poly(vinyl alcohol) for biomedical applications. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.) (2000) 41(2):1685–1686.
  • GRIFFITH LG: Polymeric biomaterials. Acta Mater. (2000) 48:263–277.
  • ••Recent review on the polymeric biomaterialdevelopment and applications.
  • LI S: Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. J. Biomed. Mater. Res. (1999) 48:342–353.
  • •Recent review on the degradation mechanism of PLGA polymers.
  • SUH H, JEONG B, RATHI R, KIM SW: Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethyleneoxide)-poly-(lactide/glycolide) nanospheres. J. Biomed. Mater. Res. (1998) 42(2):331–338.
  • KREITZ MR, DOMM JA, MATHIOWITZ E: Controlled delivery of therapeutics from microporous membranes. II. In vitro degradation and release of heparin-loaded poly(D,L-lactide-co-glycolide). Biomaterials (1997) 18(24):1645–1651.
  • BEMOIT MA, MOUSSET B, DELLOYE C, BOUILLET R, GILLARD J: Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections. Int. Orthop. (1997) 21(6):403–408.
  • SANCHEZ A, GUPTA RK, ALONSO MJ, SIBER GR, LANGER R Pulsed controlled-release system for potential use in vaccine delivery. J. Pharm. Sci. (1996) 85(0:547–552.
  • NOBES GAR, MARCHESSAULT RH, MAYSINGER D: Polyhydroxyalkanoates: Materials for delivery systems. Drug Delivery (1998) 5:161–177.
  • ••Recent review on polyhydroxyalkanoates indrug delivery.
  • MATHIOWITZ E, JACOB JS, JONG YS et al.: Biologically erodable microspheres as potential oral drug delivery systems. Nature (1997) 386:410–414.
  • ••Bioerodable polyanhydride microspheres inoral drug delivery.
  • MULLER H-M, SEEBACH D: Poly(hydroxyalkanoates): a fifth class of physiologically important organic biopolymer? Angela Chim. Intl. Ed. Engl. (1993) 32:477–502.
  • CHAPUT C, YAHIA LH, SELMANI A, RIVARD C-H: Natural poly(hydroxy-butyrate-hydroxyvalerate) polymers as degradable biomaterials. Mater. Res. Soc. Symp. Proc. (1995) 385(Polymer/Inorganic Interfaces 2):49–54.
  • GURSEL I, BALCIK C, ARICA Y, AKKUS O, AKKAS N, HASIRCI V: Synthesis and characterization of PHBV and PHEMA interpenetrating networks. Proc. Int. Symp. Controlled Release Bioact. Mater. (1997) 24th:1045–1046.
  • •Hydrophilicity and hydrophobicity balanced PHBV and PHEMA interpenetrating networks.
  • ELIGIO T, RIEUMONT J, SANCHEZ R, SILVA JFS: Characterization of chemically modified poly(3-hydroxyalkanoates) and their performance as matrix for hormone release. Angew. Makromol Chem. (1999) 270:69–75.
  • KOBAYASHI H, SHIRAKI K, IKADA Y: Toxicity test of biodegradable polymers by implantation in rabbit cornea. J. Biomed Mater. Res. (1992) 26:1463–1476.
  • WADE CWR, HEGYELI AF, KULKARNI RK: Standards for in-vitro and in-vivo comparison and qualification of bioabsorbable polymers. J. Test. Eyed. (1977) 5:397–400.
  • JALIL R-U: Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) polymers in sustained drug delivery. Drug Dev. Ind. Pharm. (1990) 16:2353–2367.
  • ENGELBERG I, KOHN J: Physico-mechanical properties of degradable polymers used in medical applications: a comparative study. Biomaterials (1991) 12:290–304.
  • RAMCHANDANI M, PANKASKIE M, ROBINSON D: The influence of manufacturing procedure on the degradation of poly(lactide-co-glycolide) 85:15 and 50:50 implants. J. Controlled Release (1997) 43(2,3):161–173.
  • RAMCHANDANIA M, ROBINSON D: In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants. J. Controlled Release (1998) 54(2):167–175.
  • MORITA T, SAKAMURAY, HORIKIRI Y, SUZUKI T, YOSHINO H: Protein encapsulation into biodegradable microspheres by a novel 5/0/W emulsion method using poly(ethylene glycol) as a protein micronization adjuvant. J. Controlled Release (2000) 69(3):435–444.
  • GASPAR MM, BLANCO D, CRUZ MEM, ALONSO MJ: Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influences of polymer properties on enzyme loading, activity and in vitro release. J. Controlled Release (1998) 52:53–62.
  • ROSA GD, IOMMELI R, LA ROTONDA MI, MIRO A, QUAGLIA F: Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres. J. Controlled Release (2000) 69(2):283–295.
  • EGILMEZ NK, JONG YS, SABEL MS, JACOB JS, MATHIOWITZ E, BANKERT RB: In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity. Cancer Res. (2000) 60(14):3832–3837.
  • CLELAND JL, JONES AJS: Stable formulation of recombinant human growth factor hormone and interferon-y for microencapsulation in biodegradable microspheres. Pharm. Res. (1996) 13(10):1464–1475.
  • CLELAND JL, MAC A, BOYD B et al.: The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm. Res. (1997) 14(4):420–425.
  • LU L, STAMATAS GN, MIKOS AG: Controlled release of transforming growth factor 131 from biodegradable polymer microparticles. J. Biomed. Mater. Res. (2000) 50:440–451.
  • ZHU G, MALLERY SR, SCHWENDEMAN SP: Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide). Nature Biotech. (2000) 18:52–57.
  • PEAN J-M, BOURY F, VENTER-JULIENNE M-C, MENEI P, PROUST J-E, BENOIT J-P: Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres? Pharm. Res. (1999) 16(8):1294–1299.
  • PETTIT DK, LAWTER JR, HUANG WJ et al.: Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSE Pharm. Res. (1997) 14(10):1422–1430.
  • JEONG B, CHOI K, BAE YH, ZENTNER G, KIM SW: New biodegradable polymers for injectable drug delivery systems. J. Controlled Release (1999) 62:109–114.
  • JEONG B, BAE YH, KIM SW: Biodegradable block copolymers as injectable drug-delivery systems. Nature (1997) 388:860–862.
  • ••Temperature sensitive PEO-PLA copolymeras injectable drug carrier.
  • LUCKE A, TESSMAR J, SCHNELL E, SCHMEER G, GOPFERICH k Biodegradable poly(D,L-lactic acid)-poly(ethylene glycol)-monomethyl ether diblock copolymers: structures and surface properties relevant to their use as biomaterials. Biomaterials (2000) 21(23):2371–2370.
  • SAITO N, OKADA T, TOBA S, MIYAMOTO S, TAKAOKA K: New synthetic absorbable polymers as BMP carriers: Plastic properties of poly-D,L-lactic acid-polyethylene glycol block copolymers. J. Biomed. Mater. Res. (1999) 47(1):104–110.
  • MOLINA I, LI S, MARTINEZ MB, VERT M: Protein release from physically crosslinked hydrogels of the PLA/PEO/PLA triblock copolymer-type. Biomaterials (2001) 22:363–369.
  • ••Physically crosslinkecl PLA/PEO/PLAhydrogel in protein delivery.
  • GOODWIN CJ, BRADEN M, DOWNES S, MARSHALL NJ: Release of bioactive human growth hormone from a biodegradable material: poly(E-caprolactone). J. Biomed. Mater. Res. (1998) 40(2):204–213.
  • LI SM, CHEN XH, GROSS RA, MCCARTHY SP: Hydrolytic degradation of PCL/PEO copolymers in alkaline media. J. Mater. Sci. Mater. Med. (2000) 11(4):227–233.
  • FENG Y, KLEE D, HOCKER H: New biomaterial. Triblock copolymers of poly D(S)-isobutyl-morpholine-2,5-dionei-poly(ethylene oxide). Materiahviss. Werkstoffiech. (1999) 30(12):862–868.
  • JOHN G, MORITA M: Synthesis and characterization of photo-crosslinked networks based on L-lactide/serine copolymers. Macromolecules (1999) 32(6):1853–1858.
  • ••Photocrosslinking of acrylatecl poly(L-lactide/serine) to form polymer networks and beads in drug delivery, copolymerisation with HEMA to be a degradable hydrogel.
  • WON CY, CHU CC, YU TJ: Novel amine-containing biodegradable polyester via copolymerisation of aspartic anhydride and 1,4-cyclohexanedimethanol. Macromol. Rapid Commun. (1996) 17(9):653–659.
  • KIM Y, ZENG F, ZIMMERMAN SC: Peptide dendrimers from natural amino acids. Chem. Euro. J. (1999) 5(7):2133–2138.
  • •Biodegradable dendrimers from natural amino acids.
  • EL-SAYED M, NAIMARK M, KIANI MF, GHANDEHARI H: Transport of macromolecular drug carriers across microvascular beds. Polym. Prep. (Am. Chem. Soc. Div. Polym. Chem.) (2000) 41 (2) :1726–1727.
  • CAMPELL P, GLOVER GL, GUNN JM: Inhibition of intracellular protein degradation by pepstatin, poly(L-lysine) and pepstatinyl-poly(L-lysine). Arch. Biochem. Biophys. (1980) 203:676–680.
  • JEONG SY, KIM SW: Biodegradable polymeric drug delivery systems. Arch. Pharm. Res. (1986) 9(2):63–73.
  • LI C, YU D, NEWMAN RA et al.: Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. Cancer Res. (1998) 58:2404–2409.
  • KISHIDA A, GOTO H, MURAKAMI K, KAKINOM K, AKASHI M: Polymer drugs and polymeric drugs. IX: synthesis and 5-fluorouracil release profiles of biodegradable polymeric prodrugs y-poly(a-hydroxy-methyl-5-fluoro-uracil-glutamate). J. Bioact. Compat. Polym. (1998) 13:222–233.
  • KISHIDA A, MURAKAMI K, GOTO H, AKASHI M: Polymer drugs and polymeric drugs. X: slow release of 5-fluorouracil from biodegradable poly(y-glutamic acid) and its benzyl ester matrices. J. Bioact. Compat. Polym. (1998) 13:270–278.
  • YOSHIDA M, ASANO M, OMICHI H,80. KATAKAI R: Environmental responsive polymers based on pendant a-amino acid groups. Hoshasen (1993) 19(3):27–37.
  • •Temperature sensitive loosely crosslinked poly(acryloyl-L-proline methyl ester).
  • NAGARSEKAR A, CRISSMAN J, CRISSMAN M, FERRARI F, CAPPELLO J, 81. GHANDEHARI H: Synthesis and characterization of pH and temperature sensitive silk-elastin-like block copolymers for controlled drug delivery. Abstr. Pap. Am. Chem. Soc. (2000) 220th: OLY-317.82.
  • ••The development of a protein-based blockcopolymer biomaterials for stimuli-sensitive drug delivery systems using genetic•engineering techniques.
  • MEYER DE, KONG GA, DEWHIRST MW, ZALUTSKY MR, CHILKOTI A: Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia. Cancer Res. (2001) 61:1548–1554.
  • ••Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia.
  • YU Y-C, TIRRELL M, FIELDS GB: Minimal lipidation stabilizes protein-like molecular architecture./ Am. Chem. Soc. (1998) 120(39):9979–9987.
  • SCHWARZE SR, HO A, VOCERO-AKBANI A, DOWDY SF: In vivo protein transduction: Delivery of biologically active protein into the mouse. Science (1999) 285:1569–1572.
  • ••Protein transduction by TAT peptidesequence.
  • YU C, KOHN J: Tyrosine-PEG-derived poly(ether carbonate)s as new biomaterials part. I: synthesis and evaluation. Biomaterials (1999) 20(3):253–264.
  • KOHN J, LANGER R Poly(iminocarbonates) as potential biomaterials. Biomaterials (1986) 7(3):176–182.
  • KOHN J: Optimization of biocompatibility and materials properties in the design of degradable biomaterials. Polym. Prepr. (Am. Chem. Soc. Div. Polym. Chem.) (1991) 32(2):223–224.
  • •Design of biodegradable polymers with defined physical, chemical, biological properties.
  • DAHIYAT BI, RICHARDS M, LEONG KW: Controlled release from poly(phosphoester) matrices. J. Controlled Release (1995) 33(1):13–21.
  • HELLER J, BARR J, NG S et al.: Development of a new family of poly(ortho esters) and their application in protein and bupivacaine delivery. Tenth International Symposium on Recent Advances in Drug Delivery Systems, Salt Lake City, Utah, USA, (2001) 49–52.
  • HELLER J, NG SY, PENHALE DW, FRITZINGER BK: Use of poly(ortho esters) for the controlled release of 5-fluorouracil and a LHRH analogue. J. Controlled Release (1987) 6:217–224.
  • HELLER J: Development of poly(ortho esters): A histological review. Biomaterials (1990) 11:659–665.
  • A review on the development and biomedical application of poly(ortho ester).
  • MERKLI A, TABATABAY C, GURNY R: Use of insoluble biodegradable polymers in ophthalmic systems for the sustained release of drugs. Euro. J. Biopharm. (1995) 41(5):271–283.
  • ALLCOCK HR, HYMER WC, AUSTIN PE: Diazocoupling of catecholamines with poly(organophosphazenes). Macromolecules (1983) 16:1401–1408.
  • WANG G, HOLLINGS WORTH RI: Synthesis and properties of a bipolar, bisphosphatidyl ethanolamine that forms stable 2-dimensional self-assembled bilayer systems and liposomes. J. Org. Chem. (1999) 64(11):4140–4147.
  • REMUNAN-LOPEZ C, LORENZO-LAMOSA ML, VILA-JATO JL, ALONSO MJ: Development of new chitosan-cellulose multicore microparticles for controlled drug delivery. Euro. J. Pharm. Biopharm. (1998) 45(1):49–56.
  • BOUHADIR KB, YUE I, CHEN L, HAUSMAN D, MOONEY DJ: Synthesis and crosslinking of partially oxidized alginate for tissue engineering applications. Book of Abstracts, 216th ACS National Meeting, Boston, USA August 23–27 (1998): BTEC–078.
  • BOUHADIR KH, ROWLEY JA, KRUGER GM, LEE KY, MOONEY DJ: Biodegradable hydrogels for controlled cell and drug delivery. Book of Abstracts, 217th ACS National Meeting, Anaheim, California, USA March 21–25 (1999): OLY–175.
  • LEE KY, PETERS MC, ANDERSON KW, MOONEY DJ: Controlled growth factor release from synthetic extracellular matrices. Nature (2000) 408:998–1000.
  • ••Mechanical-stimuli controlled growth factorrelease from alginate hydrogel. hyaluronate-hydroxyethyl acrylate blend hydrogel for controlled release device. Chem. Pharm. Bull. (2000) 48(6):850–854. Hybrid hydrogels assembled from synthetic Temperature sensitive hybrid hydrogels
  • PRESTWICH GD, LUO Y, ZIEBELL MR, VERCRUYSSE KP, KIRKER KR, MACMASTER JS: Chemically-modified hyaluronan: new biomaterials and probes for cell biology. Int. Congr. Ser. (2000) 1196:181-194 New Frontiers in Medical Sciences: Redefining Hyaluronan.
  • •Hyaluronan derivatives in drug delivery, wound healing and cell biology study.
  • VERCRUYSSE KP, PRESTWICH GD: Hyaluronate derivatives in drug delivery Crit. Rev. Therap. Drug Carr. Syst. (1998) 15:513–555.
  • ••Hyaluronan derived biomaterials in drugdelivery application.
  • LUO Y, KIRKER KR, PRESTWICH GD: Cross-linked hyaluronic acid hydrogel films: New biomaterials for drug delivery. J. Controlled Release (2000) 69:169–184.
  • LUO Y, PRESTWICH GD: Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjugate Chem. (1999) 10:755–763.
  • LUO Y, ZIEBELL MR, PRESTWICH GD: A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells. Biomacromolecules (2000) 1:208–218.
  • RADICE M, BURN P, CORTIVO R, SCAPINELLI R, BATTALIARD C, ABARTANGELO G: Hyaluronan-based biopolymers as delivery vehicles for bone-marrow-derived mesenchymal progenitors./ Biomed. Mater. Res. (2000) 50:101–109.
  • •Benzyl ester derived hyaluronan scaffold in tissue engineering.
  • CAMPOCCIA D, DOHERTY P, RADICE M, BRUN P, ABATANGELO G, WILLIAM DF: Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials (1998) 19:2101–2127.
  • FRIESS W: Collagen. Biomaterial for drug delivery. Euro. J. Pharm. Biopharm. (1998) 45(2):113–136.
  • ••Recent review on collagen in drug delivery.
  • RAO KP: Recent developments of collagen-based materials for medical applications and drug delivery systems. J. Biomater. Sci. Polym. Ed. (1995) 7(7):623–45.
  • KUIJPERS AJ, ENGBERS GHM, KRIJGSVELD J, ZAAT SAJ, DANKERT J, FEIJEN J: Crosslinking and characterization of gelatin matrices for biomedical applications. J. Biomater. Sci., Polym. Ed. (2000) 11(3):225–243.
  • INUKAI M, JIN Y, YOMOTA C, YONESE M: Preparation and characterization of hyaluronate-hydroxyethyl acrylate blend hydrogel for controlled release device. Chem. Pharm. Bull. (2000) 48(6):850–854.
  • WANG C, STEWART RJ, KOPECEK J: Hybrid hydrogels assembled from synthetic polymers and coiled-coil protein domains. Nature (1999) 397(6718):417–20
  • •• Temperature sensitive hybrid hydrogels from synthetic polymers and coiled-coil protein domains.
  • KURISAWA M, TERANO M, YUI N: Double-stimuli-responsive degradation of hydrogels consisting of oligopeptide-terminated poly(ethylene glycol) and dextran with an interpenetrating polymer network. J. Biomater. Sci., Polym. Ed. (1997) 8(9):691–708.
  • ••The biodegradability of IPN structuredhydrogel based on oligopeptide-terminated PEG and dextran exhibiting a double-stimuli-response function.
  • SASTRY TP, MADHAVAN V, NAZER MN, GOMATHINAYAGAM S, ROSE C, RAO NM: Graft copolymerization of glycidyl methactylate onto fibrin prepared from slaughter-house waste. J. Macromol Sci., Pure Appl. Chem. (1997) A34(5):915–925.
  • OOYA T, YUI N: Supramolecular-structured polymers for drug delivery. ACS Symp. Ser. (2000) 752:375-384 Controlled Drug Delivery.
  • •A stimuli-responsive polyrotaxane with supermolecular architecture assembled by cydodextrins threaded onto a PEG chain. Patents

Websites

  • PRESTWICH GD: Biomaterials from chemically-modified hyaluronan. Glycoforum (2001): http://glycoforum.gr.jp/science/ hyaluronan/HA18/HA18E.html
  • ••Recent review on the chemical modificationof hyaluronan.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.